Half-Year Liquidity Contract Statement for Valerio Therapeutics
January 31 2024 - 11:34AM
Business Wire
Regulatory News:
Valerio Therapeutics S.A. (Euronext Growth Paris:
ALVIO)
Under the liquidity contract entered into between Valerio
Therapeutics and Kepler Cheuvreux, the following resources appeared
on the liquidity account on December 31st 2023:
- 368,174 shares - € 144,918.05
- Number of executions on buy side on
semester: 324 - Number of executions on sell side on semester: 244
- Traded volume on buy side on semester: 304,205 shares for €
69,976.87 - Traded volume on sell side on semester: 223,191 shares
for € 56,117.81
As a reminder :
- the following resources appeared on the last half year
statement on 30 June 2023 on the liquidity account:
- 287,160 shares - € 156,554.06
- Number of executions on buy side on
semester: 509 - Number of executions on sell side on semester: 492
- Traded volume on buy side on semester: 634,648 shares for €
258,705.74 - Traded volume on sell side on semester: 923,185 shares
for € 402,719.91
- the following resources appeared on the liquidity account when
the activity started:
- 87,612 shares - € 196,423.24
The implementation of this report is carried out in accordance
with AMF Decision N°2021-01 of June 22nd 2021 renewing the
implementation of liquidity contracts for shares as an accepted
market practice.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240131554337/en/
Valerio Therapeutics S.A.
Valerio Therapeutics (EU:ALVIO)
Historical Stock Chart
From Nov 2024 to Dec 2024
Valerio Therapeutics (EU:ALVIO)
Historical Stock Chart
From Dec 2023 to Dec 2024